A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

about

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Item

http://www.wikidata.org/entity/Q52603856

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@en

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@nl

type

Item

label

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@en

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@nl

altLabel

A phase I study of romidepsin ...... ory peripheral T-cell lymphoma

@en

prefLabel

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@en

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@nl

P1476

A phase I study of romidepsin ...... ry peripheral T-cell lymphoma.

@en

P2093

Charnelle E Ruben

http://www.w3.org/2001/XMLSchema#string

Chitra Hosing

http://www.w3.org/2001/XMLSchema#string

Dai Chihara

http://www.w3.org/2001/XMLSchema#string

Emily T Wesson

http://www.w3.org/2001/XMLSchema#string

Felipe Samaniego

http://www.w3.org/2001/XMLSchema#string

Issa F Khouri

http://www.w3.org/2001/XMLSchema#string

Jorge E Romaguera

http://www.w3.org/2001/XMLSchema#string

Lei Feng

http://www.w3.org/2001/XMLSchema#string

Loretta Nastoupil

http://www.w3.org/2001/XMLSchema#string

Luis E Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses

Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma.

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

P304

e416-e418

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2018.187617

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29622656

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6119133

http://www.w3.org/2001/XMLSchema#string